CTI Life Sciences Fund

CTI Life Sciences Fund makes venture capital investments in high-quality emerging life science companies at the pre-clinical and clinical development stages. Our main guiding principle is to catalyze, transform, and invest in the future of life sciences across Canada, the U.S., and Europe. More than an investor - we are a Company Builder that catalyzes nascent ideas and assets into investable, scalable, and marketable biotech companies. The CTI advantages are: ▪ Enduring Value Creation Thesis Strategic buyers will pay a premium to acquire biotech companies with best-in-class assets or a platform. ▪ Differentiated Investment strategy A dual-pronged approach that focuses on both long-term value creation and an expedited exit timeline. ▪ Purposeful Portfolio Management Steer investments towards a meaningful exit by leveraging deep industry expertise and an expansive network.